FdaApplication
NDA 211415
Identifiers
- fda_app_no: NDA211415
Properties
| Property | Value |
|---|---|
| applicant_name | ESTEVE PHARMACEUTICALS SA |
| application_type | NDA |
| approval_date | 2019-10-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QUZYTTIR | CETIRIZINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION;INTRAVENOUS |
1 product